Skip to main content

$0.210 (0%)

High

$0.22

Low

$0.18

Trades

93

Turnover

$118,368

Volume

595,975
30 June 2023 at 3:57pm
Register to track EOF and receive email alerts.
Subject
EOF Ann: Quarterly Investor Update webcast

EOF Ann: Notification of cessation of securities - EOF

EOF Ann: Notification regarding unquoted securities - EOF

EOF Ann: Initial Director's Interest Notice

EOF Ann: Appointment of Director

EOF Ann: Change of Director's Interest Notice

EOF Ann: S&P DJI Announces March 2022 Quarterly Rebalance

EOF Ann: Investor Presentation 1H FY22

EOF Ann: Appendix 4D and Half Year Accounts

EOF Ann: Appendix 4C

EOF Ann: Term loan extension

EOF Ann: Change of Director's Interest Notice

EOF Ann: Change of Director's Interest Notice

EOF Ann: Change of Director's Interest Notice

EOF Ann: Change of Director's Interest Notice

EOF Ann: Change of Director's Interest Notice

EOF Ann: Notification regarding unquoted securities - EOF

EOF Ann: Appendix 3Z

EOF Ann: Ecofibre Limited Annual General Meeting Results

EOF Ann: Ecofibre Limited Annual General Meeting Speeches

EOF Ann: JobKeeper Payments Notification

EOF Ann: Change in substantial holding

EOF Ann: Cleansing Notice

EOF Ann: University of Newcastle Pain Study

EOF Ann: Appendix 4C

EOF Ann: Appendix 2A

EOF Ann: Notice of Annual General Meeting

EOF Ann: Notice of AGM Date

EOF Ann: Investor Presentation

EOF Ann: Update on Australian S3 (OTC) CBD Research

EOF Ann: Becoming a substantial holder

EOF Ann: Sustainability Report

EOF Ann: Corporate Governance Statement and Appendix 4G

EOF Ann: Annual Report

EOF Ann: Investor Presentation FY21

EOF Ann: Appendix 4E Preliminary Financial Report FY21

EOF Ann: 4Q21 Appendix 4C

EOF Ann: Update on June sales for Ananda Professional

EOF Ann: Initial Director's Interest Notice

EOF Ann: Appointment of Director

EOF Ann: Update on May sales for Ananda Professional

EOF Ann: Investor Presentation

EOF Ann: Cleansing Notice

EOF Ann: Appendix 2A

EOF Ann: Investor Update

EOF Ann: Appendix 4C

EOF Ann: Early completion of TJU Research Program

EOF Ann: Ethics Approval for Phase IIb clinical trial in Australia

EOF Ann: Appendix 2A

EOF Ann: Notification of Release of Escrowed Shares

Register to track EOF and receive email alerts.

Similar Companies

CAN
CPH
IHL
MVP
MYX
NEU
PBP
RCE
SPL